p53 expression in pterygium by immunohistochemical analysis: A series report of 127 cases and review of the literature

Cornea

Volumn 24, Issue 5, 2005, Pages 583-586

  Tsai, Yi Yu ^a,b   Chang, Kong Chao ^c   Lin, Chien Lin ^a   Lee, Huei ^b   Tsai, Fun Jen ^d   Cheng, Ya Wen ^b   Tseng, Sung Huei ^c  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Immunohistochemistry; p53; Pterygium

Indexed keywords

PROTEIN P53;

ADULT; AGED; CATARACT EXTRACTION; CONTROLLED STUDY; EYE SURGERY; FEMALE; GENE MUTATION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PTERYGIUM; REVIEW; STAINING;

AGED; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; PTERYGIUM; RETROSPECTIVE STUDIES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 21244496442     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ico.0000154404.86462.35     Document Type: Review

References (16)

1. Nigro JM, Baker SJ, Preisinger AC, et al. Mutations in the p53 gene occur in diverse human tumor types. Nature. 1989;342:705-708.
2. Beroud C, Soussi T. The UMD-p53 database: New mutations and analysis tools. Hum Mutat. 2003;21:176-181.
3. Tan DTH, Lim AS, Goh HS, et al. Abnormal expression of the p53 tumor suppressor gene in the conjunctiva of patients with pterygium. Am J Ophthalmol. 1997;123:404-405.
4. Dushku N, Reid TW. P53 expression in altered limbal basal cells of pingula, pterygia, and limbal tumors. Curr Eye Res. 1997;16:1179-1192.
5. Onur C, Orhan D, Orhan M, et al. Expression of p53 protein in pterygia. Eur J Ophthalmol. 1998;8:157-161.
6. Chowers I, Pe'er J, Zamir E, et al. Proliferative activity and p53 expression in primary and recurrent pterygia. Ophthalmology. 2001;108: 985-988.
7. Weinstein O, Rosenthal G, Zirkin H, et al. Overexpression of p53 tumor suppressor gene in pterygia. Eye. 2002;16:619-621.
8. Tan DTH, Tang WY, Liu YP, et al. Apoptosis and apoptosis related gene expression in normal conjunctiva and pterygium. Br J Ophthalmol. 2000; 84:212-216.
9. Dushku N, Hatcher SLS, Albert DM, et al. P53 expression and relation to human papillomavirus infection in pinguecula, pterygia, and limbal tumors. Arch Ophthalmol. 1999;117:1593-1599.
10. Ueda Y, Kanazawa S. Kitaoka T, et al. Immunohistochemical study of p53, p21 and PCNA in pterygium. Acta Histochem. 2001;103:159-165.
11. Reisman D, McFadden JW, Lu G. Loss of heterozygosity and p53 expression in pterygium. Cancer Lett. 2004;206:77-83.
12. Shimmura S, Ishioka M, Hanada K, et al. Telomerase activity and p53 expression in pterygia. Invest Ophthalmol Vis Sci. 2000;41:1364-1369.
13. Kastan MB, Onyekwere O, Sidransky D, et al. Participation of p53 protein in cellular response to DNA damage. Cancer Res. 1991;51:6304-6311.
14. Levine AJ. P53, the cellular gatekeeper for growth and division, [review] Cell. 1997;88:323-331.
15. Skilling JS, Sood A, Niemann T, et al. An abundance of p53 null mutations in ovarian carcinoma. Oncogene. 1996;13:117-123.
16. Sjorgen S, Inganas M, Norberg T, et al. The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry. J Natl Cancer Inst. 1996;88:173-182.